Study of 30 patients with Campylobacter spp. bacteremia;Estudio de 30 pacientes con bacteriemia por Campylobacter spp.

Medicina Clinica

Volumn 108, Issue 9, 1997, Pages 336-340

  Font, Carme ^a   Cruceta, Ana ^a   Moreno, Asunción ^a   Miró, Òscar ^a   Coll Vinent, Blanca ^a   Almela, Manuel ^a   Mensa, Josep ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; HELICOBACTER; HUMAN;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CAMPYLOBACTER FETUS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; SPAIN;

EID: 0030939194     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Vinzent R, Dumas J, Picard N. Septicèmie grave au cours de la grossesse due à un vibrion. Avortement consécutif. Bull Acad Natl Med (París) 1947; 131: 90-92.
2. Blaser MJ, Relier LB. Campylobacter enteritis. N Engl J Med 1981; 305: 1.444-1.452.
3. a ed.). Nueva York: Churchill Livingstone, 1995; 1.948-1.956.
4. Smith GS, Blaser MJ. Fatalities associated with Campylobacter jejuni infections. JAMA 1985; 253: 2.873-2.875.
5. Riley LW, Finch MJ. Results of first year of national surveillance of Campylobacter infections in the United States. J Infect Dis 1985; 151: 956-959.
6. Schonheyder HC, Sogaard P, Frederiksen W. A survey of Campylobacter bacteremia in three Danish counties, 1989 to 1994. Scand J Infect Dis 1995; 27: 145-148.
7. Shandera WX, Tormey MP, Blaser MJ. An outbreak of bacteremic Campylobacter jejuni infection. Mount Sinai J Med 1992; 59: 53-56.
8. Skirrow MB, Jones DM, Sutcliffe E, Benjamin J. Campylobacter bacteraemia in England and Wales, 1981-91. Epidemiol Infect 1993; 110: 567-573.
9. Guerrant RL, Lahita RG, Winn WC, Roberts RB. Campylobacteriosis in man: pathogenic mechanisms and review of 91 bloodstream infections. Am J Med 1978; 65: 584-592.
10. Pérez JL, Liñares J, Gudiol F, Martin R, Marne C. Bacteriemia por Campylobacter en adultos: a proposito de seis casos. Med Clin (Barc) 1983; 81: 515-517.
11. Planes A, Bartolomé R, Tortola MT, Pigrau C, Fernández F. Campylobacter spp. bacteremias. Acta Gastroenterol Belg 1993; 56 (Supl): 10.
12. Child CG III, Turcotte JG. Surgery and hypertension. En: Child CG III. editor. The liver and portal hypertension. Filadelfia: WB Saunders, 1964; 1-85.
13. HIV Centers for Diseases Control. Update: acquired immunodeficiency syndrome. MMWR 1992; 41: 1-7.
14. Morris GK, Patton CM. Campylobacter. En: Lennette EH, Balows A, Hausler WJ, Shadomy HJ, editores. Manual of Clinical Microbiology. Washington, D.C.: American Society for Microbiology, 1985; 302-308.
15. Penner JL. Campylobacter. En: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ, editores. Manual of Clinical Microbiology. Washington, D.C.: American Society for Microbiology, 1991; 402-409.
16. National Committee for Clinical Laboratory Standards. (Approved standard M2-A3). Performance standards for antimicrobial disk susceptibility tests. Villanova: National Committee for Clinical Laboratory Standards, 1984.
17. National Committee for Clinical Laboratory Standards. (Approved standard M2-A4). Performance standards for antimicrobial disk susceptibility tests. Villanova: National Committee for Clinical Laboratory Standards, 1990.
18. National Committee for Clinical Laboratory Standards. (Approved standard M2-A5). Performance standards for antimicrobial disk susceptibility tests. Villanova: National Committee for Clinical Laboratory Standards, 1993.
19. Wang WL, Blaser MJ. Detection of pathogenic Campylobacter species in blood culture systems. J Clin Microbiol 1986; 23: 709-714.
20. Blaser MJ, Perez G, Smith PF, Patton C, Tenover FC, Lastovica AJ et al. Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics. J Infect Dis 1986; 153: 552-559.
21. Blaser MJ, Smith PF, Kholer PF. Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. J Infect Dis 1985; 227-235.
22. Allos BM, Blaser MJ. Campylobacter jejuni and the expanding spectrum of related infections. Clin Infect Dis 1995; 20: 1.092-1.101.
23. Spelman DW, Davidson N, Buckmaster ND, Spicer WJ, Ryan P. Campylobacter bacteraemia: a report of 10 cases. Med J Aust 1986; 145: 503-505.
24. Ladrón de Guevara C, González J, Peña P. Bacteraemia caused by Campylobacter spp. J Clin Pathol 1994; 47: 174-175.
25. De Otero J, Borrellas X, Fort J, Camps J. Sepsis por Campylobacter jejuni e insuficiencia renal cronica terminal. Med Clin (Barc) 1993; 101: 158.
26. Molina JM, Casin I, Hausfater P, Giretti E, Welker Y, Decazes JM et al. Campylobacter infections in HIV-infected patients: clinical and bacteriological features. AIDS 1995; 9: 881-885.
27. Moreno A, Gatell JM, Mensa J, Valls ME, Vila J. Claramonte X et al. Incidencia de enteropatógenos en pacientes con infección por el virus de la inmunodeficiencia humana. Med Clin (Bare) 1994; 102: 205-208.
28. Pigrau C, Almirante B, Pahissa A, Bartolomé R. Campylobacter spp. bacteremia in AIDS patients. J Acquir Immune Defic Syndr 1995; 11: 1-2.
29. Krumholz HM, Sande MA, Lo B. Community acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology and outcome. Am J Med 1989; 86: 776-779.
30. Witt DJ, Craven DE, McCabe WR. Bacterial infections in adult patients with AIDS and AIDS-related complex. Am J Med 1987; 82: 900-906.
31. Rolston KV, Uribe-Botero G, Mansell P. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med 1987; 83: 604-605.
32. Reina J, Ros MJ, Serra A. Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatnc patients. Antimicrob Agents Chemother 1994; 38: 2.917-2.920.
33. Sánchez-Porto A, Iñigo MA, González-Serrano M, Torres-Tortosa M. Bacteriemia por Campylobacter jejuni en paciente con síndrome de inmunodeficiencia adquirida y cirrosis hepática. Med Clin (Barc) 1992; 99: 438-439.
34. Chaves F, Dronda F, González-López A. Bacteriemia por Campylobacter jejuni en pacientes infectados por el HIV. Med Clin (Barc) 1993; 100: 514.
35. Blaser MJ, Smith PF, Hopkins JA, Heinzer I, Bryner JH, Wang WL Pathogenesis of Campylobacter fetus infections: serum resistance associated with high-molecular-weight surface proteins. J Infect Dis 1987; 155: 696-706.
36. Pedro-Botet ML, Sabrià-Leal M, Carrasco I, Arnal J, Comdom MJ. Bacteriemia por Campylobacter fetus. Interés e incidencia crecientes. Med Clin (Barc) 1991; 97: 262-264.
37. Kaldor J, Speed BR. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br Med J 1984; 288: 1.867-1.870.
38. Kuroki S, Haruta T, Yoshiota M, Kobayashi N, Nukina M, Nakabishi H. Guillain-Barré syndrome associated with Campylobacter infection. Pediatr Infect Dis J 1991; 10: 149-151.
39. Ropper AH. Campylobacter diarrhea and Guillain-Barré syndrome. Arch Neurol 1988; 45: 655-656.
40. Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter lejuni infection and Guillain-Barré syndrome. N Engl J Med 1995; 333: 1.374-1.379.
41. Mishu B, Ilyas AA, Koski CL, Vriesendorp F, Cook SD, Mithen FA et al. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med 1993; 118: 947-953.
42. Pigrau C, Bartolomé R, Almirante B, Planes AM, Pahissa A. Clinical relevance and antimicrobial susceptibility pattern in Campylobacter spp. isolated from blood cultures. Abstract from 7th European Congress of Clinical Microbiology and Infectious Diseases, Viena, 1995, 54.
43. Segreti J, Gootz TD, Goodman LJ, Parkhust GW, Quinn JP, Martin BA et al. High-level quinolone resistance in clinical isolates of Campylobacter jejuni. Clin Infect Dis 1992; 165: 667-670.
44. Reina J. Resistance to fluoroquinolones in Salmonella non-typhi and Campylobacter spp. Lancet 1992; 340: 1.035-1.036.
45. Pigrau C, Almirante B, Bartolomé R, Pahissa A. Bacteriemia por Campylobacter spp. en pacientes con infección por VIH. Med Clin (Barc) 1994; 103: 239.
46. Sánchez R, Fernández-Vaca V, Diaz MD, Munoz P, Rodríguez-Créixems M, Bouza E. Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides. Antimicrob Agents Chemother 1994; 38: 1.879-1.882.
47. Gómez-Garcés JL, Cogollos R, Alós JI. Susceptibilities of fluorquinolone-resistant strains in Campylobacter jejuni to 11 oral antimicrobial agents. Antimicrob Agents Chemother 1995; 39: 542-544.